122.
When precision matters,
122 electrodes are everything.
122 electrodes for high-density mapping and precise, patient-specific ablation.
Integrated high-density mapping
Capture over 2,500 contact-filtered points per minute1 of atrial activity to inform ablation strategy
Selective electrode targeting
Tailor each application by selecting between 2 and 64 electrodes
Thermal contact assessment
Visualize electrode-tissue contact to support precise ablation planning
Single-shot, contiguous lesions2,3
Deliver durable pulmonary vein isolation with an average of one application per vein
Select between 2 and 64 electrodes to shape lesion geometry according to anatomy and contact
“It’s a one-stop shop, personalized to the lesion set you need to deliver.”
Christopher Woods, MD, Ph.D., FHRS
One.
When workflow matters,
an all-in-one catheter is everything.
🠑
Global Atrial Map
🠑
Array Map
🠑
EGM Panel
One catheter engineered for real-time procedural adaptability and workflow efficiency
- Collect over 2,500 contact-filtered points per minute1 with a 122-electrode array, producing high-fidelity electrograms with reduced far-field noise.
- Deliver targeted ablation across evolving procedural needs, supporting circumferential, linear, focal and area lesion sets.
- Pace and capture with the Globe® Pulsed Field System to assess for conduction block.
Zero.
When safety matters,
zero catheter exchanges mean everything.
PULSAR IDE Clinical Summary1
The global, multicenter PULSAR IDE Study demonstrated the safety and effectiveness of the Globe Pulsed Field System in treating patients with paroxysmal atrial fibrillation.
Device-related primary safety event rate
Veins durably isolated in repeat ablation procedures
12-month freedom from atrial arrhythmia
Average application per vein for successful acute isolation
Resources
Product Brochure
Download the brochure to learn about the key features and benefits of the Globe Pulsed Field System
Product Spec Sheet
Download the technical specifications for the Globe Pulsed Field System
PULSAR IDE Trial Summary
Download the summary for an overview of the key safety and efficacy outcomes from the PULSAR IDE clinical trial
PULSE-EU Trial Summary
Download the summary for an overview of key safety and efficacy outcomes from the PULSE-EU clinical trial
1 Data on file.
2 Reddy V, et al. Pulsed-Field Ablation to Enhance the Durability of Pulmonary Vein Isolation and Treat Paroxysmal Atrial Fibrillation. J Am Coll Cardiol. 2026 Jan 21.
3 Turagam M, et al. AF ablation using a novel “single-shot” map-and-ablate spherical array pulsed field ablation catheter: 1-Year outcomes of the first-in-human PULSE-EU trial. Heart Rhythm. 2024;21(8):1218-1226.
